News

FierceBiotech

Selecta fuses with Cartesian in reverse merger, bolstering finances for autoimmune cell therapy goals

Selecta Biosciences is jumping into Cartesian’s cell therapy cockpit, preparing to take flight once again after landing nearly all of its previous programs. The two companies announced a reverse ...
Business Wire

Tiedemann Group and Alvarium Investments Complete Business Combination with Cartesian Growth Corporation

NEW YORK--(BUSINESS WIRE)--Tiedemann Group (“Tiedemann”), Alvarium Investments Limited (“Alvarium”) and Cartesian Growth Corporation (“Cartesian”) (NASDAQ: GLBL) announced today that they have ...
Nasdaq

Cartesian Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Initiation of Phase 3 AURORA trial of Descartes-08 in myasthenia gravis expected in 2Q25; deep and sustained benefits observed through Month 12 after a single course of therapy in Phase 2b trial ...
Nasdaq

Tiedemann Group and Alvarium Investments Announce Transaction to Form Alvarium Tiedemann Holdings and List on Nasdaq via Business Combination with Cartesian Growth Corporation

NEW YORK--(BUSINESS WIRE)-- Tiedemann Group1 (“Tiedemann”), Alvarium Investments Limited2 (“Alvarium”) and Cartesian Growth Corporation3 (“Cartesian ...